Filing Details
- Accession Number:
- 0001683168-22-000103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-05 19:54:18
- Reporting Period:
- 2022-01-03
- Accepted Time:
- 2022-01-05 19:54:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
704562 | Avid Bioservices Inc. | CDMO | Pharmaceutical Preparations (2834) | 953698422 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1346342 | R Daniel Hart | 2642 Michelle Drive, Suite 200 Tustin CA 92780 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Acquisiton | 2022-01-03 | 500 | $5.66 | 27,833 | No | 4 | M | Direct | |
Common Stock, $0.001 Par Value | Disposition | 2022-01-03 | 500 | $29.07 | 27,333 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2022-01-03 | 500 | $0.00 | 500 | $5.66 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
232,380 | 2028-08-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 15, 2021.
- Stock option granted to the reporting person on August 1, 2018, vests in four (4) equal annual installments beginning August 1, 2019 and each year thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.